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Transcription factor-based cellular reprogramming
has opened the way to converting somatic cells to
a pluripotent state, but has faced limitations resulting
from the requirement for transcription factors and the
relative inefficiency of the process. We show here
that expression of the miR302/367 cluster rapidly
and efficiently reprograms mouse and human
somatic cells to an iPSC state without a requirement
for exogenous transcription factors. This miRNA-
based reprogramming approach is two orders of
magnitude more efficient than standard Oct4/Sox2/
Klf4/Myc-mediated methods. Mouse and human
miR302/367 iPSCs display similar characteristics to
Oct4/Sox2/Klf4/Myc-iPSCs, including pluripotency
marker expression, teratoma formation, and, for
mouse cells, chimera contribution and germline
contribution. We found that miR367 expression is
required for miR302/367-mediated reprogramming
and activates Oct4 gene expression, and that
suppression of Hdac2 is also required. Thus, our
data show thatmiRNA andHdac-mediated pathways
can cooperate in a powerful way to reprogram
somatic cells to pluripotency.
INTRODUCTION
The transformation of differentiated cells to induced pluripotent
stem cells (iPSCs) has revolutionized stem cell biology by
providing a more tractable source of pluripotent cells for regen-
erative therapy. Although powerful, there are currently several
limitations to iPSC generation, including the rather low efficiency
of the process (0.2%–1.0%) and the necessity of forced expres-
sion of at least one pluripotent stem cell transcription factor,
including Oct4, Nanog, Sox2, Klf4, and/or Myc. These limitations
hamper the use of iPSC technology in high throughput formats
such as generation of human iPSC clones from large patient
populations.376 Cell Stem Cell 8, 376–388, April 8, 2011 ª2011 Elsevier Inc.The current standard strategy for iPSC generation relies upon
ectopic expression of Oct4, Sox2, Klf4, and Myc (OSKM)
(Takahashi and Yamanaka, 2006). Although there are several
alternatives to some of these factors, including the use of other
transcription factors, signaling factors, and pharmacological
molecules, at least one pluripotent stem cell transcription
factor—usually Oct4—is required for efficient iPSC reprogram-
ming (Huangfu et al., 2008a, 2008b; Judson et al., 2009; Melton
et al., 2010; Yoshida et al., 2009). Recently, several microRNAs
(miRNAs) have been shown to enhance iPSC reprogramming
when expressed along with combinations of the OSKM factors
(Judson et al., 2009). These miRNAs belong to families of
miRNAs that are expressed preferentially in embryonic stem
cells and are thought to help maintain the ESC phenotype
(Babiarz et al., 2008;Wang et al., 2007, 2008;Wang andBlelloch,
2009;). How these miRNAs enhance iPSC reprogramming is
unclear but may have to do with their ability to regulate the cell
cycle (Judson et al., 2009).
Of the miRNAs expressed at high levels in ESCs and iPSCs,
the miR302/367 cluster has been shown to be a direct target
of Oct4 and Sox2 (Card et al., 2008), two of the critical factors
required for iPSC reprogramming. Levels of miR302/367 corre-
late with Oct4 transcripts in ESCs and early embryonic devel-
opment, indicating an important role in ESC homeostasis
and maintenance of pluripotency (Card et al., 2008). Despite
their ability to enhance iPSC reprogramming in the presence
of several of the OSKM factors (Judson et al., 2009), the
ability of these miRNAs to directly reprogram somatic cells to
an iPSC phenotype is unclear. We show that expression of
the miR302/367 cluster can directly reprogram mouse and
human somatic cells to a pluripotent stem cell state in the
absence of any of the previously described pluripotent stem
cell transcription factors. Reprogramming by miR302/367 is
up to two orders of magnitude more efficient than that with
the OSKM factors. We also show that valproic acid (VPA) is
required for reprogramming mouse fibroblasts by specifically
degrading Hdac2 protein, a finding that is supported by the
efficient reprogramming of Hdac2/ fibroblasts in the absence
of VPA. Thus, the expression of miR302/367 along with
Hdac2 suppression allows for highly efficient iPSC reprogram-
ming without the expression of the known reprogramming
factors.
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Figure 1. miR302/367 Can Reprogram Mouse Fibroblasts to a Pluripotent Stem Cell Phenotype
(A) The sequences of the miR302/367 cluster showing the similarity between members of the miR302a/b/c/d subfamily. miR367 has a different seed sequence
than miR302a/b/c/d.
(B) Schematic of viral expression protocol for miR302/367 iPSC reprogramming with VPA. Day 0 is the start of viral transduction.
(C) Oct4-GFP-positive miR302/367 clones at 7 days after starting viral transduction.
(D) AP staining of a primary induction plate of miR302/367 iPSC clones at 8 days after starting viral transduction.
(E) Immunostaining for Nanog, Oct4, Sox2, and SSEA1 in both mouse ES and primary induction samples ofmiR302/367 iPSCs at day 10, showing expression of
pluripotent genes.
See also Figures S1 and S2. Scale bars, 100 mm.
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miR302/367 Reprograms Fibroblasts to an iPSC
Phenotype
Previous studies have shown that the miR302/367 cluster
comprises five miRNAs, four of which—miR302a/b/c/d—have
identical seed sequences (Card et al., 2008; Figure 1A). The
miR302/367 cluster is located in intron 8 of the Larp7 gene on
chromosome 3 and is transcribed as a single polycistronic
primary transcript (Card et al., 2008). The sequences of the
miR302/367 miRNAs are highly conserved across species
(Card et al., 2008; Rosa et al., 2009). To determine whether
expression of miR302/367 could reprogram somatic cells, we
generated a lentiviral vector, which expressed the 690 bp region
encoding the mouse miR302/367 sequences, and used it to
transfect mouse embryonic fibroblasts (MEFs) derived from
the Oct4-GFP mouse line (Lengner et al., 2007; Figure 1B). We
included the Hdac inhibitor VPA in these experiments, as thishas been shown to enhance iPSC reprogramming (Huangfu
et al., 2008a). Surprisingly, we observed clones derived from
miR302/367-transduced MEFs within 6 to 8 days after the start
of a viral infection that had already assumed an ESC-like
morphology (Figures 1C and 3A). Most of these clones were
Oct4-GFP positive and alkaline-phosphatase positive (Figures
1C and 1D). These clones also expressed Nanog, Sox2, and
SSEA1 (Figure 1E). In comparison, parallel expression of
OSKM-expressing viruses in addition to VPA did not result in
any visible clones until at least 8–10 days after starting viral
transduction (Figure 3 and data not shown). Use of a polycis-
tronic virus did not alter the timing or overall number of colonies
generated by OSKM expression (data not shown and Sommer
et al., 2009). Moreover, in the absence of VPA, miR302/367
was unable to reprogram MEFs efficiently (see below and data
not shown).
We further characterized the miR302/367-generated iPSC
clones by microarray analysis for their similarity at the globalCell Stem Cell 8, 376–388, April 8, 2011 ª2011 Elsevier Inc. 377
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Figure 2. miR302/367 iPSC Clones Have a Similar Expression Profile as Mouse ESCs
(A) Microarray experiments were used to show the similarity between miR302/367 iPSC clones C6, C7, and C10 at passage 15 and the mouse ESC line R1.
(B) Heatmap of pluripotent gene expression of mouse ESC line R1 and miR302/367 iPSC clones C6, C7, and C10 from experiment in (A).
(C) Q-PCR of pluripotent gene expression of miR302/367 iPSC clones C6, C7, and C10 at passage 15 and mouse ESC line R1.
See also Figures S1 and S2.
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at passage 15 for these analyses. These data show a very high
degree of correlation with global gene expression in the R1378 Cell Stem Cell 8, 376–388, April 8, 2011 ª2011 Elsevier Inc.ESC line (Figures 2A and 2B). These clones lacked integration
of any of the OSKM factors that we use as controls, but did
contain viral integration of the miR302/367 lentivirus into the
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miRNA-Mediated Pluripotent Stem Cell Reprogramminggenome (see Figure S1 available online). miR302/367 iPSC
clones that have been passaged serially maintain their ESC-
like morphology and Q-PCR shows that they exhibit identical
expression of pluripotent genes as mouse ESCs (Figure 2C
and data not shown). Moreover, the miR302/367 lentivirus is
silenced at later passages (Figure S2). These results suggest
that expression of miR302/367 in addition to VPA was able to
reprogram mouse MEFs to an iPSC state without expression of
other previously described pluripotent factors.
miR302/367 Reprogramming is More Efficient
Than OSKM Reprogramming
The rapid appearance of miR302/367-reprogrammed iPSCs
suggested that expression of these miRNAs improved the
temporal kinetics of reprogramming. To test this hypothesis,
we expressed in parallel miR302/367 and the OSKM genes
using an identical number of starting MEFs and viral titer. VPA
was included in both OSKM as well as miR302/367-reprogram-
ming experiments. Previous studies have demonstrated that
using the OSKM factors, an average colony-forming reprogram-
ming efficiency of 0.2%–0.8% is observed (Huangfu et al.,
2008a). Using miR302/367, we consistently observed Oct4-
GFP-positive clones 7 days after starting viral transduction,
which is sooner than cells transduced in parallel with the
OSKM factors (Figure 3A). By counting the number of clones
with ES-like morphology at 8 and 10 days after starting viral
transduction, we show that expression ofmiR302/367 produces
two orders of magnitude more iPSC clones than when the
OSKM factors are used (Figure 3B). At day 10, 79.8% of
miR302/367 iPSC clones exhibited robust expression of Oct4-
GFP, which is greater than clones expressing the OSKM factors,
of which only approximately 50% express Oct4-GFP
(Figure 3C).
To better quantify this increase in iPSC reprogramming effi-
ciency, we performed quantitative real-time PCR (Q-PCR) for
pluripotent marker genes during the first 8 days of the reprog-
ramming process on primary induction plates. The experiment
used the same number of starting MEFs and viral titer for infec-
tion. These data indicate that while cells transduced with the
OSKM factors expressed only very low levels of pluripotent
marker genes during this time period, miR302/367-transduced
cells expressed all of the genes examined at robust levels by
day 8 (Figure 3D). The numbers of clones were such that after
8–10 days, the plates containing the miR302/367 iPSC clones
became overcrowded, resulting in decreased cell viability
unless they were isolated and expanded. We also assessed
the efficiency of reprogramming by miR302/367 using fluores-
cence-activated cell sorting (FACS) for expression of GFP
from the Oct4 locus in Oct4-GFP MEFs (Lengner et al., 2007).
OSKM-reprogrammed MEFs do show Oct4-GFP expression
at both 6 and 8 days of the reprogramming process, with up
to 17% of cells expressing GFP by day 8, which is in the
same range as previously reported (Figure 3E; Huangfu et al.,
2008a). However, miR302/367 is able to activate Oct4-GFP
expression in up to 80% of MEFs after 8 days of reprogram-
ming (Figure 3E). These data support the conclusion that
miR302/367 is able to reprogram fibroblasts to a pluripotent
state up to two orders of magnitude more efficiently than
OSKM factors.miR302/367 iPSCs Can Generate Derivatives of
Mesoderm, Endoderm, and Ectoderm in Teratomas;
Generate Adult Chimeras; and Contribute to the Mouse
Germline
To more fully characterize the pluripotent characteristics
of miR302/367 iPSCs, we generated teratomas in immune-
deficient mice with multiple miR302/367 iPSC clones. miR302/
367 iPSC-derived teratomas formed readily and exhibited
tissues representing all three germ layers, as noted by structures
resembling muscle fibers, keratinized epidermal cells, and
luminal structures lined with gut-like epithelium (Figure 4A).
Supporting these morphological findings, neural epithelial-like
structures were positive for bIII-tubulin expression, muscle-like
structures were positive for myosin heavy-chain expression,
and gut-like epithelium was positive for E-cadherin expression
(Figure 4B). A more stringent assay for pluripotency is deter-
mining whether miR302/367 iPSCs can generate tissues within
the developing embryo using chimeric embryo analysis. There-
fore, we generated miR302/367 iPSC clones from MEFs made
from the Rosa26lacZ mouse line which expresses b-galactosi-
dase ubiquitously (Friedrich and Soriano, 1991). Injection of
these miR302/367 iPSC clones generated high-percentage
chimeras in more than 50% of the injected embryos (Figure 4C
and data not shown). Most of these chimeras exhibited 80%–
95% contribution from miR302/367 iPSCs to all tissues exam-
ined (Figure 4C and Figure S3).
To test whether miR302/367 iPSCs could contribute to
the germline of mice, we injected three different mouse
miR302/367 iPSC clones derived from Oct4-GFP MEFs. Mouse
gonads were collected at E13.5 and E15.5 and visualized both
by whole-mount fluorescence and then fixed and sectioned for
immunostaining for GFP expression. All three clones contrib-
uted efficiently to germ cells in the gonads of chimeric mice
(Figures 4D–4J). Moreover, miR302/367 iPSC clones generated
from C57BL/6 MEFs can generate high-percentage postnatal
chimeras, although germline transmission has not yet been
examined (Figure 4K). Thus, miR302/367 iPSC clones are
pluripotent, are competent to generate all three germ layers,
and contribute efficiently to the germline of mice. A summary
of mouse clones tested for pluripotency is found in Table S1.
miR302/367 Can Reprogram Human Fibroblasts to
a Pluripotent State More Efficiently Than OSKM Factors
To assess whether miR302/367 can reprogram human fibro-
blasts, we transduced human foreskin and dermal fibroblasts
with themiR302/367 lentivirus. Within 12–14 days, we observed
clones with the classic human ESC morphology (Figure 5A).
Immunostaining of these clones showed they expressed
OCT4, SSEA4, TRA-1-60, and TRA-1-81 (Figures 5B–5E).
Q-PCR using three different miR302/367 hiPSC cell clones
shows that they all express pluripotent markers at levels equiva-
lent to the hESC line HUES13 (Figure 5F). We reprogrammed the
human foreskin fibroblast cell line BJ and performed DNA finger-
printing to show that clones from miR302/367 reprogramming
are derived from the original parental BJ line (Figure S4). More-
over, these human clones did not contain any integrants of the
OSKM viruses, and the miR302/367 virus was silenced in later
passages (Figures S1 and S2). Interestingly, VPA was not
required for reprogramming human fibroblasts and its additionCell Stem Cell 8, 376–388, April 8, 2011 ª2011 Elsevier Inc. 379
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Figure 3. miR302/367Plus VPA is TwoOrders ofMagnitudeMore Efficient ThanOSKMFactors in iPSCReprogramming ofMouse Fibroblasts
(A) miR302/367 iPSC clones are readily observed 6 to 7 days after starting viral transduction and express high levels of Oct4-GFP while OSKM-induced clones
are not observed until 8–10 days, are very rare, and do not express significant levels of GFP from the Oct4 locus.
(B) Counts of clones with ES-like morphology from transduction of 1.75 3 104 Oct4-GFPMEFs with equivalent amounts of either OSKM ormiR302/367 virus at
8 and 10 days after viral transduction. Data are the average of three assays ± SEM.
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miRNA-Mediated Pluripotent Stem Cell Reprogrammingdid not affect the efficiency of reprogramming (see below and
data not shown). Teratomaswere generated from seven different
miR302/367 hiPSC clones and all exhibited formation of
mesoderm, endoderm, and ectoderm (Figures 5G–5L). A
summary of human clones tested for pluripotency is found in
Table S1.
We next assessed whether there was an increase in human re-
programming efficiency similar to what we observed in MEFs.
Starting with the same number of human foreskin fibroblasts
and OSKM and miR302/367 viral titers, the number of colonies
with ES-like morphology formed at 18 and 26 days after starting
viral transduction is two orders of magnitude greater formiR302/
367 than when using OSKM expression (Figure 5M). Based on
the cell counts, approximately 10% of human fibroblasts used
for viral transduction produce iPSC clones (Figure 5M). Q-PCR
from primary induction plates also reveals a dramatic increase
in pluripotent gene expression inmiR302/367-expressing versus
OSKM-expressing human foreskin fibroblasts (Figure 5N). These
data indicate that miR302/367 can reprogram human as well as
mouse fibroblasts to an iPSC state with greatly increased
efficiency.
miR367 Expression is Required for miR302/367
iPSC Reprogramming
The miR302/367 cluster contains five different miRNAs,
miR302a/b/c/d and miR367. All are expressed from a common
promoter located in intron 8 of the Larp7 gene (Card et al.,
2008). miR302a/b/c/d all share a common seed sequence
suggesting that they target a similar set of mRNAs and thus
may act redundantly (Figure 1A). However, miR367 has
a different seed sequence and thus may target a different set
of mRNAs (Figure 1A). Therefore, we tested whether miR367
expression is required for miR302/367 iPSC reprogramming.
Using a lentivirus lacking the miR367 sequence, we infected
Oct4-GFP MEFs alongside the miR302/367 lentivirus and as-
sessed pluripotent reprogramming by colony counts, Q-PCR,
and FACS analysis. The miR302a/b/c/d virus lacking miR367 is
expressed at high levels in MEFs (Figure 6A). However,
miR302a/b/c/d did not generate any iPSC colonies when
expressed in MEFs at day 10 of reprogramming (Figure 6B).
Continued culture for up to 3 weeks did not result in formation
of any iPSC colonies from miR302a/b/c/d-transduced MEFs
(data not shown). Moreover, expression of miR367 alone did
not reprogram fibroblasts (data not shown). Q-PCR of primary
induction plates 8 days after viral transduction shows that
several important pluripotent genes were expressed at lower
levels in miR302a/b/c/d-transduced MEFs versus miR302/367-
transduced MEFs (Figure 6C). Importantly, Oct4 expression is
not observed at detectable levels in response tomiR302a/b/c/d
expression (Figure 6C, arrow). Using FACS analysis and
Oct4-GFP MEFs, we show that there is no induction of Oct4
gene expression when expressing miR302a/b/c/d without
miR367whilemiR302/367 expression induces robustOct4-GFP
expression by day 8 (Figure 6D). These data show that without(C) Percentage of Oct4-GFP-positive clones 10 days after viral transduction with
(D) Q-PCR of the indicated pluripotent factors comparing OSKM versus miR302
(E) FACS analysis of miR302/367-reprogrammed Oct4-GFP MEFs compared to
bars, 50 mm.miR367 expression, miR302a/b/c/d expression was unable to
reprogram mouse MEFs and that this correlated with a lack of
induction of Oct4 gene expression. Thus, the coordinated action
of the miR302a/b/c/d family along with miR367 is required for
iPSC reprogramming.
Low Levels of Hdac2 Permit miR302/367
Reprogramming
Recent evidence has pointed to an important role for chromatin
remodeling factors in regulating the ESC pluripotent state
(Lagarkova et al., 2010; Mali et al., 2010). Previous data have
shown that VPA, a known Hdac inhibitor, enhances OSKM re-
programming, suggesting an important role for Hdac-mediated
chromatin remodeling in iPSC reprogramming (Huangfu et al.,
2008a). We initially found that, in the absence of VPA, miR302/
367 was unable to efficiently reprogram MEFs to iPSCs and of
the few clones that did develop, none survived clonal replating
(Figures 7D and 7F and data not shown). Interestingly, VPA
was not necessary for reprogramming of human foreskin or
dermal fibroblasts (Figure 5). VPA has been reported to specifi-
cally degrade Hdac2 protein (Kramer et al., 2003). Therefore,
we assessed whether expression of class I Hdacs was altered
by miR302/367 or VPA treatment by performing western blots
for Hdac1, -2, and -3 expression during miR302/367-mediated
reprogramming. While Hdac1 and Hdac3 expression levels
were unchanged in all conditions, VPA caused degradation of
Hdac2 protein in MEFs (Figure 7A). Expression of miR302/367
did not affect the levels of Hdac1, -2, or -3 in the presence or
absence of VPA in MEFs (Figure 7A). In contrast, human foreskin
fibroblasts expressed much lower levels of Hdac2 protein, and
the protein levels of Hdac2 were not affected by VPA in these
cells (Figure 7B). These data suggest that low levels of Hdac2
may significantly enhance or even be required for miR302/367
reprogramming and that human fibroblasts express much lower
levels of Hdac2 than MEFs.
To test whether suppression of Hdac2 is specifically required
for efficient reprogramming by miR302/367, we generated
Hdac2/ MEFs from Hdac2flox/flox mice using adenoviral-medi-
ated cre excision of Hdac2 and determined whether loss of
Hdac2 altered the efficiency of miR302/367 reprogramming of
MEFs in the absence of VPA (Figure S5). We found that in
Hdac2/ MEFs transduced with the miR302/367 virus,
Oct4-GFP-positive clones were observed as early as 6 days
post-viral infection (Figure 7C). Eight days after viral transduc-
tion, Hdac2/ MEFs had formed significant numbers of iPSC
clones in the absence of VPA, whereas wild-type MEFs in the
absence of VPA did not generate any viable clones (Figure 7D).
VPA addition to Hdac2/ MEFs did not change the number of
iPSC clones obtained (Figure 7D). The number of iPSC clones
generated and the percentage of clones that were Oct4-GFP
positive with miR302/367-transduced wild-type MEFs plus
VPA and miR302/367-transduced Hdac2/ MEFs lacking
VPA were similar (Figure 7D and 7E). Loss of Hdac2 expression
or VPA addition did not affect proliferation rates in MEFsOSKM or miR302/367. Data are the average of three assays ± SEM.
/367 during the first 8 days after viral transduction.
OSKM-reprogrammed MEFs at 6 and 8 days post-viral transduction. Scale
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Figure 4. miR302/367 iPSCs Can Generate Derivatives of Mesoderm, Endoderm, and Ectoderm and Contribute to the Germline of Mice
(A) Hematoxylin and eosin staining of teratomas derived from mouse miR302/367 iPSC clones showing skin epidermal-like structures, muscle, and gut-like
epithelium. These data are representative of five different miR302/367 iPSC clones, all of which were injected and produced teratomas.
(B) Immunostaining of mouse miR302/367 iPSC-derived teratoma tissues showing expression of bIII-tubulin-positive neural epithelium, MF20-positive striated
muscle, and E-cadherin-positive endodermal cells.
(C)miR302/367 iPSC clones can generate all tissues within the developing mouse embryo as shown by lacZ histochemical staining of high-percentage chimeric
embryos derived from Rosa26-miR302/367 iPSC clones at both E9.5 and E13.5.
(D–J) Both whole-mount fluorescence (D) and immunostaining forOct4-GFP protein expression (E–J) show high-level contribution ofmiR302/367 iPSC clones to
the germline within the gonads of recipient mice. The data are representative of three clones (C6, C7, C10), which were injected into blastocysts and all three
contributed to the germline.
(K) miR302/367 iPSCs generated from C57BL/6 MEFs generate high-percentage postnatal chimeras as noted by coat color.
See also Figure S3. Scale bars: (A), 100 mm; (B, D, G, H, and J), 150 mm; (F and I), 100 mm.
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miRNA-Mediated Pluripotent Stem Cell Reprogramming(Figure S6). Q-PCR to assess expression of pluripotency-related
genes also shows increased reprogramming by miR302/367 in
Hdac2/ MEFs compared to wild-type MEFs without VPA (Fig-382 Cell Stem Cell 8, 376–388, April 8, 2011 ª2011 Elsevier Inc.ure 7F). Thus, low levels of Hdac2 or suppression of Hdac2 is
required for efficient pluripotent stem cell reprogramming by
miR302/367.
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Current strategies for generating iPSCs rely upon expression
of multiple pluripotent stem-cell-associated transcription
factors. We show that a single miRNA cluster, miR302/367,
can reprogram fibroblasts more efficiently than the standard
OSKMmethod. With ongoing advances in miRNA biology, these
findingsmay lead to a nonviral, nontranscription-factor mediated
procedure for generating iPSCs for use not only in basic stem cell
biology studies, but also for high throughput generation of
human iPSC clones from large patient populations.
Previous studies have demonstrated the usefulness of iPSCs
not only in the study of basic stem cell biology, but also in the
ability to generate patient-specific iPSC clones, which can
then be further differentiated into the cell lineage of choice,
including hematopoietic, cardiomyocyte, and hepatocyte cell
lineages (Moretti et al., 2010a, 2010b; Raya et al., 2010; Si-Tayeb
et al., 2010). However, at this point the low efficiency of iPSC re-
programming is an impediment to adapting the process to high-
throughput approaches. Such approaches would allow for the
generation of iPSC clones from large patient populations ob-
tained from genome-wide association studies for use in charac-
terizing the identified genomic differences at the cell biological
level. Our finding that reprogramming by miR302/367 is up to
two orders of magnitude more efficient than the OSKM factors
suggests that this method may prove to be amenable for use
in large-scale iPSC generation. Several other reports have
demonstrated that using techniques including Sendai viral
expression as well as direct transfection of synthesized mRNAs
for the OSKM factors can improve the efficiency of iPSC reprog-
ramming (Seki et al., 2010; Warren et al., 2010). Based on our
data, we obtain efficiencies that are greater than either of these
techniques, and using human fibroblasts, the percentage of cells
that generate iPSC clones approaches 10%. Thus, miR302/367
iPSC reprogramming is more efficient than previously described
methods, including transfection of synthetic mRNAs for OSKM
factors (Warren et al., 2010).
Themechanismunderlying the increased efficiency ofmiR302/
367 iPSC reprogramming is likely to revolve in part around the
nature of miRNA biology. First, miRNA expression does not
require protein translation and thus leads to a fast response on
protein expression based on inhibition of mRNA translation and
stability. Second, miRNAs generally target scores or hundreds
of mRNAs that coordinate expression of many different proteins,
which can rapidly impose a dominant phenotypic change in cell
identity. This ability to target many different mRNAs also simulta-
neously increases the complexity underlying the mechanism of
miR302/367 function. miR302/367 collectively targets hundreds
of different mRNA targets, including those that regulate chro-
matin remodeling and cell proliferation based on bioinformatic
prediction algorithms (Betel et al., 2008; Grimson et al., 2007;
Krek et al., 2005). Our data indicate that miR367 expression is
essential for iPSC reprogramming by the miR302/367 cluster.
AsmiR367 has a different seed sequence, suggesting a different
set of mRNA targets, analysis of the combinatorial regulation of
miR302a/b/c/d and miR367 targets may provide important
information regarding both the pluripotent gene network and
also factors whose expression is required to be suppressed for
efficient iPSC reprogramming.Our studies underscore the role of Hdac2 in iPSC reprogram-
ming. The specific degradation of Hdac2 protein by VPA is likely
the reason that this small molecule has been found to be more
efficacious than other Hdac enzymatic inhibitors in enhancing
iPSC reprogramming (Huangfu et al., 2008a). Several recent
studies have demonstrated the importance of other chromatin
remodeling processes in iPSC reprogramming (Bhutani et al.,
2010; Lagarkova et al., 2010; Mali et al., 2010). Hdac2 has also
been found to be part of an extended regulatory network for
pluripotency in ESCs by interacting with both Oct4 and Myc
(Kim et al., 2008). Since iPSC reprogramming involves the reset-
ting of the epigenetic state of a differentiated cell to a pluripotent
‘‘ground state,’’ additional studies into the necessity of chro-
matin remodeling will likely lead to better insight into cell lineage
transdifferentiation events. Our finding that human cells, which
express much lower levels of Hdac2 protein, do not require
VPA for miR302/367-mediated reprogramming suggests that
differing levels of Hdac2 may account, at least in part, for the
different iPSC reprogramming efficiencies exhibited by different
cell lineages. Moreover, Hdac2 expression may decline during
development such that adult cells have little Hdac2 protein,
resulting in the absence of an affect by VPA. Future studies
into whether these correlations exist more broadly in other cell
lineages may be beneficial for optimizing reprogramming by
other methods including the OSKM factors.
Our studies show that miRNAs can be powerful tools for
mediating iPSC reprogramming without the need for pluripotent
factors including the OSKM factors. The current focus on devel-
oping miRNAs for therapeutic use could lead to a nonviral
mediated method of altering miR302/367 expression, which
could in turn allow for a rapid miRNA/small molecule approach
for iPSC reprogramming.EXPERIMENTAL PROCEDURES
Lentiviral Vector Construction
A mouse genomic DNA fragment comprising miR302/367 or miR302a/b/c/d
family of miRNA was amplified by PCR using primers listed in Table S1. The
amplified fragment was cloned into Acc65I and XhoI restriction enzyme sites
of pENTR1A entry vector (Invitrogen) and verified by sequencing. The fragment
was excised from the entry vector and ligated into BsrGI site of pLOVE desti-
nation vector (Blelloch et al., 2007) resulting in pLOVE-miR302/367 vector. The
pLOVE-miR302a/b/c/d vector was generated in the same fashion, but using
a different 30 primer that excluded the miR367 sequence.Cell Culture, Viral Production, and Induction of Pluripotent
Stem Cells
Mouse fibroblasts were isolated from Oct4-GFP, Rosa26-LacZ, and
Hdac2flox/flox embryos at E13.5 and cultured in fibroblast medium as described
(Takahashi et al., 2007). Hdac2 was excised by infection of Hdac2flox/floxMEFs
with adeno-cre virus. Human dermal fibroblasts were cultured in DMEM/F12,
15%FBS, penicillin/streptomycin, and L-glutamine. Viral particles were gener-
ated by transfection of plated 293T cells with pLOVE vectors encoding
miR302/367, Oct4, Sox2, Klf4, or N-myc along with pMD.G and psPAX2
vectors as described (Blelloch et al., 2007). Supernatant from the transfected
cells were collected every 24 hr for 48 hr and titered. The titered viral suspen-
sion was mixed with 0.5 ml of 10 mg/ml polybrene (American Bioanalytical, MA)
per milliliter of viral suspension and used to infect fibroblasts. After viral infec-
tion, mouse fibroblasts were cultured inmouse ESmedium supplementedwith
or without valproic acid at a final concentration of 2mM for the indicated length
of time. Infected human fibroblasts were cultured in human ES medium as
described (Huangfu et al., 2008a; Takahashi et al., 2007).Cell Stem Cell 8, 376–388, April 8, 2011 ª2011 Elsevier Inc. 383
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Figure 5. miR302/367 Reprograms Human Fibroblasts to a Pluripotent State More Efficiently Than OSKM Factors
(A–E) Colony morphology and OCT4, SSEA4, TRA-1-60, and TRA-1-81 immunostaining of miR302/367-reprogrammed human fibroblasts.
(F) Q-PCR of pluripotent stem cell marker genes in three differentmiR302/367-reprogrammed human fibroblast lines as compared to the human ES line HUES13.
(G–I) Hematoxylin and eosin staining of teratomas derived frommiR302/367 human iPSC clones showing endoderm (gut)-, mesoderm (muscle)-, and ectoderm
(neural epithelium)-like structures. These data represent the results from seven human miR302/367 iPSC clones.
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Figure 6. miR367 Expression is Required for miR302/367 iPSC Reprogramming
(A) The miR302a/b/c/d pre-miRNA is expressed at high levels in transduced MEFs.
(B) Number of colonies generated after 10 days of miR302a/b/c/d or miR302/367 expression. Data are the average of four assays ± SEM.
(C) Pluripotent gene expression from primary induction plates 8 days after viral induction of miR302a/b/c/d or miR302/367 viruses. Note lack of Oct4 gene
expression in miR302a/b/c/d-expressing cells (red arrow). Data are the average of three assays ± SEM.
(D) FACS analysis of Oct4-GFP MEFs 8 days after transduction with either miR302a/b/c/d or miR302/367 viruses.
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Cloneswerewashed twice in PBS (withMg2+ andCa2+) and fixed in 3.7% form-
aldehyde. Cells were permeabilized in 0.2% Nonidet P40 (Roche) and blocked
in 10% goat serum. Cells were incubated in the following primary antibodies
at 4C overnight: Oct3/4 (Santa Cruz Biotechnology), Sox2 (R&D Systems),
Nanog (Abcam), SSEA1 and SSEA4 (Developmental Studies Hybridoma
Bank), TRA-1-60andTRA-1-81 (Millipore, Inc.), andGFP (Clontech). Secondary
antibodies areAlexaFluor 488and568 (Invitrogen). Themountingmediumused
was Vectorshield with DAPI (Vector Laboratories). Alkaline phosphatase histo-
chemical staining was performed using SIGMAFAST Fast Red TR/Naphtol
AS-MX tablets following manufacturer’s instructions (Sigma-Aldrich).
RNA Isolation, Quantitative RT-PCR, and Microarray Experiments
Total RNA was isolated using Trizol (Invitrogen). Two micrograms of RNA were
used to synthesize cDNA using Superscript First Stand Synthesis Kit (Invitro-
gen). Real-time PCR was performed using SYBR Green (Applied Biosystems)
by 7900HT Fast Real-Time PCR System (Applied Biosystems). Real-time
primer sequences are listed in Table S1. For microarray experiments, the(J–L) Immunostaining ofmiR302/367 human iPSC-derived teratoma tissues show
muscle, and bIII-tubulin-positive neural epithelium.
(M) Efficiency ofmiR302/367 reprogramming in human foreskin fibroblasts by colo
transduction. Data are the average of three assays ± SEM.
(N) Q-PCR of pluripotent gene expression in miR302/367-reprogrammed huma
average of three assays ± SEM.
See also Figures S1, S2, and S4. Scale bars: (A–E), 50 mm; (G–L), 150 mm.Affymetrix Mouse Gene 1.0 ST arrays were used. Microarray data were
analyzed using Robust Multichip Analysis (RMA) and Principal Component
Analysis (PCA) and the Partek Genomics Suite v6.5.
Teratoma Formation and DNA Fingerprinting Analysis
miR302/367 iPSCs were passaged twice on 0.1% gelatin-coated plates for an
hour to remove feeders. A total of 5 3 105 cells were mixed with Matrigel and
injected into each flank of NOD-SCIDmice. Tumors were harvested at 4 weeks
postinjection, fixed in 4% paraformaldehyde, and embedded in paraffin.
Sectioned tumors were stained for hematoxylin and eosin. For immunofluores-
cence staining, the primary antibodies were bIII-tubulin (Abcam), MF-20
(Developmental Studies Hybridoma Bank), and E-cadherin (Cell Signaling).
Genomic DNA from humanmiR302/367 iPSC clones was used for DNA finger-
printing analysis (Cell Line Genetics, LLC, Madison, WI.).
Generation of Mouse Chimeras with miR302/367 iPSC Clones
miR302/367 iPSCs were generated using Rosa26-LacZ mouse embryonic
fibroblasts (Friedrich and Soriano, 1991). The cells were passaged twice oning expression of E-cadherin-positive endodermal cells, MF20-positive striated
ny counts of cloneswith human ES-like morphology at 18 and 26 days postviral
n foreskin fibroblasts at 18 and 26 days postviral transduction. Data are the
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Figure 7. VPA Specifically Degrades Hdac2 Protein, and Suppression of Hdac2 is Required for iPSC Reprogramming by miR302/367
(A) VPA specifically degrades Hdac2, but not Hdac1 or Hdac3 proteins. Expression ofmiR302/367 alone did not have any effect on Hdac1, -2, or -3 protein levels.
(B) Human foreskin fibroblasts express much lower levels of Hdac2 than MEFs.
(C) Hdac2/MEFs, in the absence of VPA, start to reprogram between 6 and 7 days postviral transduction, which is similar to wild-type MEFs treated with VPA.
(D) Number of clones generated withHdac2/MEFs in the absence of VPA is similar toHdac2+/+MEFswith VPA at 8 days postviral transduction.Hdac2+/+MEFs
without VPA treatment did not generate any viable clones and VPA addition to Hdac2/ MEFs did not increase the number of clones generated.
(E) Percentage of Oct4-GFP-positive clones is similar for Hdac2+/+ MEFs with VPA treatment and Hdac2/ MEFs without VPA treatment at 8 days postviral
transduction.
(F) Q-PCR for pluripotent stem cell marker genes shows enhanced expression of pluripotency markers at day 8 of reprogramming by miR302/367 in wild-type
(Hdac2+/+) and Hdac2/ MEFs versus WT MEFs without VPA treatment. Data are the average of three assays ± SEM.
See also Figures S5 and S6.
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Cell Stem Cell
miRNA-Mediated Pluripotent Stem Cell Reprogramming0.1% gelatin-coated plates for an hour to remove feeders and injected into
E3.5 C57BL/6 blastocysts. Embryos were harvested at E9.5 and E13.5 and
stained for LacZ activity using previously described methods (Shu et al.,
2002). For germline contribution experiments, miR302/367 iPSC clones C6,
C7, and C10, which were generated fromOct4-GFPMEFs, were used for blas-
tocyst injections. Gonads were harvested from E13.5 and E15.5 embryos,
visualized by fluorescence microscopy, and then fixed and sectioned for
GFP immunostaining. Embryos and tissues were embedded in paraffin and
sectioned as described (Cohen et al., 2009; Shu et al., 2002). All three clones
contributed to the germline.Western Blots
Total cell lysates were prepared for western blotting as previously described
(Trivedi et al., 2008). Equal amounts of protein were resolved by SDS-PAGE
and transferred to polyvinylidenedifluoride membranes. Membranes were
incubated with Hdac1 antibody (1:1000 dilution, Cell Signaling), Hdac2
antibody (1:1000 dilution, Invitrogen), or Hdac3 antibody (1:1000 dilution,
Sigma). Primary antibody binding was visualized by HRP-conjugated
secondary antibody and detected by enhanced chemiluminescence (LumiGlo,
Cell Signaling). For loading control, membranes were reprobed with primary
antibody against GAPDH (1:2500 dilution, Abcam).Proliferation Assays
Proliferation assays for MEFs were performed using the CellTiter 96 Aqueous
One Solution Cell Proliferation kit (Promega, Inc.). Twenty microliters of Cell-
Titer Reagent, which functions by being incorporated by viable cells into
a colorimetric product that can be measured at 490 nm, was added to 100
ml of culture medium, incubated at 37C, and absorbance was measured at
490 nm at 1.5 hr, 2.5 hr, and 4.5 hr.Generation of Conditional Hdac2flox/flox Mice
TheHdac2flox/flox allele was generated by flanking exon 2 with loxP recombina-
tion sites using the targeting vector depicted in Figure S5A. Upon cre-medi-
ated recombination, exon 2 is deleted and the resulting mRNA is out of frame
with multiple early stop codons producing premature termination and loss of
Hdac2 protein. This construct was electroporated into R1 ESCs; correctly tar-
geted ES clones were identified using Southern blot analysis (Figure S5B) and
used to generate high percentage chimeras and germline transmission of the
Hdac2flox/+ allele. Ubiquitous CMV-Cre transgenic mice were used to delete
Hdac2 and to demonstrate the resulting loss of Hdac2 protein by western
blot analysis (Figure S4C). Hdac2flox/flox mice were crossed with Oct4-GFP
knock-in mice (Lengner et al., 2007) to generate Hdac2flox/flox:Oct4-GFP
mouse embryonic fibroblasts, which were treated with adenovirus-expressing
cre recombinase to delete Hdac2 for reprogramming experiments.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
1016/j.stem.2011.03.001.ACKNOWLEDGMENTS
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